All About Multiple Sclerosis

More MS news articles for April 2003

Overview of the potential benefits of intravenous immunoglobulins in neurological practice

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12661417&dopt=Abstract

Postepy Hig Med Dosw 2002;56 Suppl:69-83
Lewanska M, Selmaj K.
Klinika Neurologii Akademii Medycznej w Lodzi.

Intravenous immunoglobulin (IVIG) has been used in a wide range of neurological conditions.

Clinical effect of IVIG has been shown in controlled trials in patients with Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, dermatomyositis and recently in multiple sclerosis.

This article aims to provide clinicians with an overview of the potential benefits of intravenous immunoglobulins in neurological practice.